Cell-Type-Specific Transcriptomic Alterations in the Epileptic Prefrontal Cortex and Complementary Neuroimaging Findings in an Independent Cohort.
- 1Neurology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, CHN.
- 2Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN.
- 3Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, CHN.
Abstract
Background and objectives
Epilepsy is a complex neurological disorder involving distributed neuronal and glial networks. The cellular transcriptional states associated with epilepsy and their relationship to macroscopic brain abnormalities remain incompletely characterized. We therefore performed a two-part exploratory study using a public postmortem prefrontal cortex (PFC) single-nucleus RNA sequencing (snRNA-seq) dataset and an independent clinical neuroimaging cohort.Methods
Public snRNA-seq data from eight individuals classified as having epilepsy and seven controls were processed with CellRanger (10x Genomics, Pleasanton, California) and Seurat (Satija Lab, New York Genome Center, New York, New York). Cell-type composition, exploratory nucleus-level differential expression, Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, Monocle pseudotime analysis, and SCENIC (Single-Cell rEgulatory Network Inference and Clustering) regulon inference were evaluated. Separately, 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT) and diffusion tensor imaging (DTI) data from 16 patients with neocortical epilepsy were analyzed using within-patient lesion-versus-contralateral comparisons. Because the sequencing and imaging cohorts were independent, the two components were interpreted as complementary observations rather than direct cross-modal validation.Results
After quality control, 16,132 nuclei were retained (11,587 control and 4,545 epilepsy nuclei). Oligodendrocyte-lineage representation was lower in epilepsy than in controls (5.3% vs. 14.7%; exploratory P = 0.023), whereas layer 2/3 (L2/3) excitatory neurons showed higher representation (47.7% vs. 29.5%). Exploratory cell-level enrichment analysis identified MAPK-related signaling as the top-ranked KEGG pathway among upregulated genes in L2/3 neurons, and SCENIC identified a STAT3 (signal transducer and activator of transcription 3)-associated reactive astrocytic regulon pattern. Oligodendrocyte-lineage nuclei showed altered gene-expression patterns and different distributions along an inferred pseudotime continuum; these observations were not interpreted as direct evidence of impaired differentiation. In the independent imaging cohort, PET signal was lower in epileptic lesions than in contralateral regions (P = 0.007), and fractional anisotropy (FA) was reduced (P < 0.001), whereas mean diffusivity (MD) was not significantly different (P = 0.101). PET and FA findings remained significant after Bonferroni correction for three prespecified imaging comparisons (adjusted threshold P < 0.0167).Conclusions
The study identifies exploratory cell-type-specific transcriptional alterations in the public PFC dataset and, independently, metabolic and white matter microstructural abnormalities in a separate neocortical epilepsy cohort. These findings represent complementary observations across different biological scales rather than direct molecular-imaging validation. Larger donor-level transcriptomic studies, matched molecular-imaging cohorts, and functional experiments are required to validate the candidate cellular and molecular signatures.
Related
- Multimodal neuroimaging of cue-induced craving and cortical alterations in etomidate use disorder
- Selective behavioral and prefrontal transcriptomic correlates of acute clozapine exposure in socially isolated mice
- Admission blood glucose and neutrophil-to-lymphocyte ratio provide independent and complementary prognostic value for in-hospital mortality in acute type A aortic dissection
- Substantia nigra iron-related alterations, white matter disruption, and functional network dysconnectivity in temporal lobe epilepsy: a multimodal neuroimaging study.
- Concurrent TMS-EEG to characterise interhemispheric signal propagation over the motor and prefrontal regions: An independent replication of GABAB receptor mechanisms
BibTeX
@article{chen2026celltypespecific,
title = {{Cell-Type-Specific Transcriptomic Alterations in the Epileptic Prefrontal Cortex and Complementary Neuroimaging Findings in an Independent Cohort.}},
author = {Jing Chen and Yuqi Ying and Cheng Wang and Zhoule Zhu and Jingquan Lin and Junming Zhu and Zhe Zheng},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116642},
url = {https://europepmc.org/article/MED/42909952},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cell-Type-Specific Transcriptomic Alterations in the Epileptic Prefrontal Cortex and Complementary Neuroimaging Findings in an Independent Cohort.
AU - Jing Chen
AU - Yuqi Ying
AU - Cheng Wang
AU - Zhoule Zhu
AU - Jingquan Lin
AU - Junming Zhu
AU - Zhe Zheng
PY - 2026
DA - 2026/09/21
JO - Cureus
DO - 10.7759/cureus.116642
UR - https://europepmc.org/article/MED/42909952
AB - Background and objectives Epilepsy is a complex neurological disorder involving distributed neuronal and glial networks. The cellular transcriptional states associated with epilepsy and their relationship to macroscopic brain abnormalities remain incompletely characterized. We therefore performed a two-part exploratory study using a public postmortem prefrontal cortex (PFC) single-nucleus RNA sequencing (snRNA-seq) dataset and an independent clinical neuroimaging cohort.Methods Public snRNA-seq data from eight individuals classified as having epilepsy and seven controls were processed with CellRanger (10x Genomics, Pleasanton, California) and Seurat (Satija Lab, New York Genome Center, New York, New York). Cell-type composition, exploratory nucleus-level differential expression, Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, Monocle pseudotime analysis, and SCENIC (Single-Cell rEgulatory Network Inference and Clustering) regulon inference were evaluated. Separately, 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT) and diffusion tensor imaging (DTI) data from 16 patients with neocortical epilepsy were analyzed using within-patient lesion-versus-contralateral comparisons. Because the sequencing and imaging cohorts were independent, the two components were interpreted as complementary observations rather than direct cross-modal validation.Results After quality control, 16,132 nuclei were retained (11,587 control and 4,545 epilepsy nuclei). Oligodendrocyte-lineage representation was lower in epilepsy than in controls (5.3% vs. 14.7%; exploratory P = 0.023), whereas layer 2/3 (L2/3) excitatory neurons showed higher representation (47.7% vs. 29.5%). Exploratory cell-level enrichment analysis identified MAPK-related signaling as the top-ranked KEGG pathway among upregulated genes in L2/3 neurons, and SCENIC identified a STAT3 (signal transducer and activator of transcription 3)-associated reactive astrocytic regulon pattern. Oligodendrocyte-lineage nuclei showed altered gene-expression patterns and different distributions along an inferred pseudotime continuum; these observations were not interpreted as direct evidence of impaired differentiation. In the independent imaging cohort, PET signal was lower in epileptic lesions than in contralateral regions (P = 0.007), and fractional anisotropy (FA) was reduced (P < 0.001), whereas mean diffusivity (MD) was not significantly different (P = 0.101). PET and FA findings remained significant after Bonferroni correction for three prespecified imaging comparisons (adjusted threshold P < 0.0167).Conclusions The study identifies exploratory cell-type-specific transcriptional alterations in the public PFC dataset and, independently, metabolic and white matter microstructural abnormalities in a separate neocortical epilepsy cohort. These findings represent complementary observations across different biological scales rather than direct molecular-imaging validation. Larger donor-level transcriptomic studies, matched molecular-imaging cohorts, and functional experiments are required to validate the candidate cellular and molecular signatures.
SN - 2168-8184
ER -